Twenty-three percent of working-age adults with health insurance face high out-of-pocket costs that make it difficult to ...

The Biden administration is attempting to push through a slew of reforms to the controversial MA program in its final months ...

Sanofi plans to phase in its own rebate model for 25 drugs — including anti-inflammatory injectable Dupixent, one of the top ...

CHS first announced plans to offload its three-hospital Commonwealth Health System to WoodBridge in July. The nonprofit ...

About 7.4 million Americans with obesity could have insurance coverage for drugs like Wegovy if the Trump administration ...

Insurers could save 20% in administrative costs and 10% in medical costs by harnessing the technology, experts said during a ...

The HHS’ Office for Civil Rights’ audit program was too narrow in scope to effectively assess data protections and reduce ...

A Texas federal judge has sided with UnitedHealthcare in determining regulators messed up calculating its Medicare Advantage ...

A prolific medical researcher and author, Martin Makary criticized the FDA and CDC for their decision-making during the ...

In 2024, coverage for obesity drugs increased to 44% among employers with 500 or more workers, compared to 41% last year, the ...

contextflow’s AI-driven technology enables radiologists to track lung nodules over time, assess malignancy, and generate high ...